Baorto et al evaluated pediatric patients with febrile neutropenia following cancer therapy. They used the absolute monocyte count to stratify patients as to risk of serious complications. The authors are from Washington University, University of Texas Southwestern Medical Center and M.D. Anderson Cancer Center.